These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15786906)

  • 1. [Targeting--a new way to identify unknown tumor markers in blood vessels].
    Wallin E; Akerman ME; Palmblad J
    Lakartidningen; 2005 Feb 21-27; 102(8):551-2, 554-5. PubMed ID: 15786906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell receptors for glucagon/GLP-1? Properties of exendin(9-39) in mouse islets.
    Kofod H; Kirk O; Adelhorst K
    Acta Physiol Scand; 1996 Jul; 157(3):347. PubMed ID: 8830890
    [No Abstract]   [Full Text] [Related]  

  • 3. New diabetes drugs target gut hormones.
    Kuehn BM
    JAMA; 2006 Jul; 296(4):380-1. PubMed ID: 16868285
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
    Schirra J; Sturm K; Leicht P; Arnold R; Göke B; Katschinski M
    J Clin Invest; 1998 Apr; 101(7):1421-30. PubMed ID: 9525985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies in anti-vascular cancer therapy.
    Bloemendal HJ; Logtenberg T; Voest EE
    Eur J Clin Invest; 1999 Sep; 29(9):802-9. PubMed ID: 10469169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer.
    Rajabi M; Adeyeye M; Mousa SA
    Curr Med Chem; 2019; 26(30):5664-5683. PubMed ID: 31250748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor vasculature with homing peptides from phage display.
    Ruoslahti E
    Semin Cancer Biol; 2000 Dec; 10(6):435-42. PubMed ID: 11170865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proglucagon-derived peptides: mechanisms of action and therapeutic potential.
    Sinclair EM; Drucker DJ
    Physiology (Bethesda); 2005 Oct; 20():357-65. PubMed ID: 16174875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel therapy in type 2 diabetes: to regulate glucose metabolism naturally].
    MMW Fortschr Med; 2005 Aug; 147(31-32):54-5. PubMed ID: 16128202
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of diabetes mellitus. New developments and hopes].
    Verspohl EJ
    Med Monatsschr Pharm; 2005 Jun; 28(6):193-202; quiz 203. PubMed ID: 15960421
    [No Abstract]   [Full Text] [Related]  

  • 12. Local, exendin-(9-39)-insensitive, site of action of GLP-1 in canine ileum.
    Daniel EE; Anvari M; Fox-Threlkeld JE; McDonald TJ
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G595-602. PubMed ID: 12181172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression by exendin(9-39)amide of glucagon-like peptide-1 insulinotropic action in rats infused with dimethyl ester of succinic acid.
    Cancelas J; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ
    Endocrine; 2001 Aug; 15(3):283-5. PubMed ID: 11762700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer drug targets: approaching angiogenesis.
    Keshet E; Ben-Sasson SA
    J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors.
    Balestrieri ML; Napoli C
    Eur J Cancer; 2007 May; 43(8):1242-50. PubMed ID: 17449238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 agonists.
    Padwal R
    BMJ; 2012 Jan; 344():d7282. PubMed ID: 22236410
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential role of vascular targeted therapy to combat against tumor.
    Chen B; Jin H; Wu K
    Expert Opin Drug Deliv; 2009 Jul; 6(7):719-26. PubMed ID: 19538038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.
    During MJ; Cao L; Zuzga DS; Francis JS; Fitzsimons HL; Jiao X; Bland RJ; Klugmann M; Banks WA; Drucker DJ; Haile CN
    Nat Med; 2003 Sep; 9(9):1173-9. PubMed ID: 12925848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incretin mimetics as emerging treatments for type 2 diabetes.
    Joy SV; Rodgers PT; Scates AC
    Ann Pharmacother; 2005 Jan; 39(1):110-8. PubMed ID: 15562141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.